Total number of protein in "GO:1902495" GO term: 257
| Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCA2_ENST00000371605 | ABCA2 | Q9BZC7 | ATP-binding cassette sub-family A member 2 | chr9 | GO:1902495 | Not Cancer Driver | No | 240 | 0.099 | 497 | 44 | 0.089 | 0 |
| ABCB6 | ABCB6 | Q9NP58 | ATP-binding cassette sub-family B member 6 | chr2 | GO:1902495 | Not Cancer Driver | No | 87 | 0.103 | 27 | 1 | 0.037 | 11 |
| ABCB8 | ABCB8 | Q9NUT2 | Mitochondrial potassium channel ATP-binding subunit | chr7 | GO:1902495 | Not Cancer Driver | No | 117 | 0.159 | 55 | 5 | 0.091 | 0 |
| ABCC8_ENST00000389817 | ABCC8 | Q09428 | ATP-binding cassette sub-family C member 8 | chr11 | GO:1902495 | Not Cancer Driver | No | 255 | 0.161 | 138 | 23 | 0.167 | 97 |
| ABCC9_ENST00000261201 | ABCC9 | O60706 | ATP-binding cassette sub-family C member 9 | chr12 | GO:1902495 | Not Cancer Driver | No | 368 | 0.238 | 132 | 30 | 0.227 | 15 |
| ABCD4 | ABCD4 | O14678 | Lysosomal cobalamin transporter ABCD4 | chr14 | GO:1902495 | Not Cancer Driver | No | 77 | 0.127 | 6 | 1 | 0.167 | 3 |
| ABCG5_ENST00000405322 | ABCG5 | Q9H222 | ATP-binding cassette sub-family G member 5 | chr2 | GO:1902495 | Not Cancer Driver | No | 77 | 0.118 | 43 | 8 | 0.186 | 6 |
| ABCG8 | ABCG8 | Q9H221 | ATP-binding cassette sub-family G member 8 | chr2 | GO:1902495 | Not Cancer Driver | No | 137 | 0.204 | 40 | 8 | 0.2 | 10 |
| ABHD12_ENST00000339157 | ABHD12 | Q8N2K0 | Lysophosphatidylserine lipase ABHD12 | chr20 | GO:1902495 | Not Cancer Driver | No | 45 | 0.113 | 8 | 1 | 0.125 | 1 |
| ABHD6 | ABHD6 | Q9BV23 | Monoacylglycerol lipase ABHD6 | chr3 | GO:1902495 | Not Cancer Driver | No | 38 | 0.113 | 11 | 2 | 0.182 | 0 |
| AKAP9 | AKAP9 | Q99996 | A-kinase anchor protein 9 | chr7 | GO:1902495 | Census | Yes | 474 | 0.121 | 2281 | 268 | 0.117 | 1 |
| ANO1 | ANO1 | Q5XXA6 | Anoctamin-1 | chr11 | GO:1902495 | Not Cancer Driver | No | 155 | 0.157 | 168 | 14 | 0.083 | 0 |
| ANO2_ENST00000327087 | ANO2 | Q9NQ90 | Anoctamin-2 | chr12 | GO:1902495 | Not Cancer Driver | No | 239 | 0.238 | 277 | 48 | 0.173 | 0 |
| ANO6_ENST00000320560 | ANO6 | Q4KMQ2 | Anoctamin-6 | chr12 | GO:1902495 | Not Cancer Driver | No | 134 | 0.147 | 80 | 11 | 0.138 | 0 |
| ATP12A_ENST00000381946 | ATP12A | P54707 | Potassium-transporting ATPase alpha chain 2 | chr13 | GO:1902495 | Not Cancer Driver | No | 203 | 0.195 | 117 | 24 | 0.205 | 0 |
| ATP1A1_ENST00000295598 | ATP1A1 | P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 | chr1 | GO:1902495 | Census | Yes | 115 | 0.112 | 115 | 16 | 0.139 | 6 |
| ATP1A2 | ATP1A2 | P50993 | Sodium/potassium-transporting ATPase subunit alpha-2 | chr1 | GO:1902495 | Not Cancer Driver | No | 230 | 0.225 | 161 | 34 | 0.211 | 8 |
| ATP1A3_ENST00000302102 | ATP1A3 | P13637 | Sodium/potassium-transporting ATPase subunit alpha-3 | chr19 | GO:1902495 | Not Cancer Driver | No | 200 | 0.197 | 115 | 29 | 0.252 | 31 |
| ATP1A4 | ATP1A4 | Q13733 | Sodium/potassium-transporting ATPase subunit alpha-4 | chr1 | GO:1902495 | Not Cancer Driver | No | 195 | 0.19 | 117 | 24 | 0.205 | 0 |
| ATP1B1 | ATP1B1 | P05026 | Sodium/potassium-transporting ATPase subunit beta-1 | chr1 | GO:1902495 | Not Cancer Driver | No | 38 | 0.125 | 55 | 9 | 0.164 | 0 |
| ATP1B2 | ATP1B2 | P14415 | Sodium/potassium-transporting ATPase subunit beta-2 | chr17 | GO:1902495 | Not Cancer Driver | No | 40 | 0.138 | 16 | 6 | 0.375 | 0 |
| ATP1B3 | ATP1B3 | P54709 | Sodium/potassium-transporting ATPase subunit beta-3 | chr3 | GO:1902495 | Not Cancer Driver | No | 36 | 0.129 | 6 | 1 | 0.167 | 0 |
| ATP1B4 | ATP1B4 | Q9UN42 | Protein ATP1B4 | chrX | GO:1902495 | Not Cancer Driver | No | 85 | 0.238 | 79 | 18 | 0.228 | 0 |
| ATP4B | ATP4B | P51164 | Potassium-transporting ATPase subunit beta | chr13 | GO:1902495 | Not Cancer Driver | No | 35 | 0.12 | 2 | 0 | 0.0 | 0 |
| BEST1_ENST00000378043 | BEST1 | O76090 | Bestrophin-1 | chr11 | GO:1902495 | Not Cancer Driver | No | 47 | 0.08 | 229 | 18 | 0.079 | 108 |
| BEST2_ENST00000042931 | BEST2 | Q8NFU1 | Bestrophin-2 | chr19 | GO:1902495 | Not Cancer Driver | No | 64 | 0.126 | 90 | 3 | 0.033 | 0 |
| BEST3 | BEST3 | Q8N1M1 | Bestrophin-3 | chr12 | GO:1902495 | Not Cancer Driver | No | 161 | 0.241 | 266 | 72 | 0.271 | 0 |
| BEST4 | BEST4 | Q8NFU0 | Bestrophin-4 | chr1 | GO:1902495 | Not Cancer Driver | No | 40 | 0.085 | 148 | 6 | 0.041 | 0 |
| CACNA1C | CACNA1C | Q13936 | Voltage-dependent L-type calcium channel subunit alpha-1C | chr12 | GO:1902495 | Not Cancer Driver | No | 455 | 0.205 | 744 | 146 | 0.196 | 14 |
| CACNA1D_ENST00000350061 | CACNA1D | Q01668 | Voltage-dependent L-type calcium channel subunit alpha-1D | chr3 | GO:1902495 | Census, Compendium | Yes | 342 | 0.158 | 736 | 126 | 0.171 | 2 |
| CACNA1G | CACNA1G | O43497 | Voltage-dependent T-type calcium channel subunit alpha-1G | chr17 | GO:1902495 | Not Cancer Driver | No | 367 | 0.154 | 1022 | 149 | 0.146 | 3 |
| CACNA1H | CACNA1H | O95180 | Voltage-dependent T-type calcium channel subunit alpha-1H | chr16 | GO:1902495 | Not Cancer Driver | No | 323 | 0.137 | 1045 | 141 | 0.135 | 18 |
| CACNA1I | CACNA1I | Q9P0X4 | Voltage-dependent T-type calcium channel subunit alpha-1I | chr22 | GO:1902495 | Not Cancer Driver | No | 272 | 0.122 | 870 | 73 | 0.084 | 0 |
| CACNA1S | CACNA1S | Q13698 | Voltage-dependent L-type calcium channel subunit alpha-1S | chr1 | GO:1902495 | Not Cancer Driver | No | 389 | 0.208 | 382 | 76 | 0.199 | 6 |
| CACNA2D1_ENST00000356253 | CACNA2D1 | P54289 | Voltage-dependent calcium channel subunit alpha-2/delta-1 | chr7 | GO:1902495 | Not Cancer Driver | No | 277 | 0.251 | 99 | 25 | 0.253 | 0 |
| CACNB2 | CACNB2 | Q08289 | Voltage-dependent L-type calcium channel subunit beta-2 | chr10 | GO:1902495 | Not Cancer Driver | No | 155 | 0.235 | 478 | 106 | 0.222 | 0 |
| CACNB3 | CACNB3 | P54284 | Voltage-dependent L-type calcium channel subunit beta-3 | chr12 | GO:1902495 | Not Cancer Driver | No | 58 | 0.12 | 258 | 30 | 0.116 | 0 |
| CACNG1 | CACNG1 | Q06432 | Voltage-dependent calcium channel gamma-1 subunit | chr17 | GO:1902495 | Not Cancer Driver | No | 36 | 0.162 | 0 | 0 | 0.0 | 0 |
| CACNG2 | CACNG2 | Q9Y698 | Voltage-dependent calcium channel gamma-2 subunit | chr22 | GO:1902495 | Not Cancer Driver | No | 57 | 0.176 | 90 | 16 | 0.178 | 1 |
| CACNG3 | CACNG3 | O60359 | Voltage-dependent calcium channel gamma-3 subunit | chr16 | GO:1902495 | Not Cancer Driver | No | 126 | 0.4 | 69 | 37 | 0.536 | 0 |
| CACNG4 | CACNG4 | Q9UBN1 | Voltage-dependent calcium channel gamma-4 subunit | chr17 | GO:1902495 | Not Cancer Driver | No | 51 | 0.156 | 71 | 17 | 0.239 | 0 |
| CACNG5_ENST00000307139 | CACNG5 | Q9UF02 | Voltage-dependent calcium channel gamma-5 subunit | chr17 | GO:1902495 | Not Cancer Driver | No | 77 | 0.28 | 1 | 0 | 0.0 | 0 |
| CACNG6 | CACNG6 | Q9BXT2 | Voltage-dependent calcium channel gamma-6 subunit | chr19 | GO:1902495 | Not Cancer Driver | No | 49 | 0.188 | 19 | 2 | 0.105 | 0 |
| CACNG7 | CACNG7 | P62955 | Voltage-dependent calcium channel gamma-7 subunit | chr19 | GO:1902495 | Not Cancer Driver | No | 99 | 0.36 | 9 | 1 | 0.111 | 0 |
| CACNG8 | CACNG8 | Q8WXS5 | Voltage-dependent calcium channel gamma-8 subunit | chr19 | GO:1902495 | Not Cancer Driver | No | 47 | 0.111 | 205 | 15 | 0.073 | 0 |
| CALM1 | CALM1 | P0DP23 | Calmodulin-1 | chr14 | GO:1902495 | Not Cancer Driver | No | 19 | 0.128 | 115 | 15 | 0.13 | 7 |
| CALM2 | CALM2 | P0DP24 | Calmodulin-2 | chr2 | GO:1902495 | Not Cancer Driver | No | 18 | 0.121 | 115 | 13 | 0.113 | 8 |
| CALM3_ENST00000596362 | CALM3 | P0DP25 | Calmodulin-3 | chr19 | GO:1902495 | Not Cancer Driver | No | 17 | 0.114 | 115 | 10 | 0.087 | 3 |
| CCDC51 | CCDC51 | Q96ER9 | Mitochondrial potassium channel | chr3 | GO:1902495 | Not Cancer Driver | No | 51 | 0.124 | 137 | 21 | 0.153 | 0 |
| CFTR | CFTR | P13569 | Cystic fibrosis transmembrane conductance regulator | chr7 | GO:1902495 | Not Cancer Driver | No | 287 | 0.194 | 145 | 18 | 0.124 | 151 |
| CHRFAM7A | CHRFAM7A | Q494W8 | CHRNA7-FAM7A fusion protein | chr15 | GO:1902495 | Not Cancer Driver | No | 40 | 0.097 | 18 | 0 | 0.0 | 0 |
| CHRNA1_ENST00000348749 | CHRNA1 | P02708 | Acetylcholine receptor subunit alpha | chr2 | GO:1902495 | Not Cancer Driver | No | 86 | 0.188 | 9 | 1 | 0.111 | 12 |
| CHRNA2 | CHRNA2 | Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | chr8 | GO:1902495 | Not Cancer Driver | No | 85 | 0.161 | 33 | 5 | 0.152 | 1 |
| CHRNA3 | CHRNA3 | P32297 | Neuronal acetylcholine receptor subunit alpha-3 | chr15 | GO:1902495 | Not Cancer Driver | No | 86 | 0.17 | 11 | 1 | 0.091 | 0 |
| CHRNA4 | CHRNA4 | P43681 | Neuronal acetylcholine receptor subunit alpha-4 | chr20 | GO:1902495 | Not Cancer Driver | No | 144 | 0.23 | 186 | 33 | 0.177 | 2 |
| CHRNA5 | CHRNA5 | P30532 | Neuronal acetylcholine receptor subunit alpha-5 | chr15 | GO:1902495 | Not Cancer Driver | No | 63 | 0.135 | 24 | 3 | 0.125 | 0 |
| CHRNA6 | CHRNA6 | Q15825 | Neuronal acetylcholine receptor subunit alpha-6 | chr8 | GO:1902495 | Not Cancer Driver | No | 101 | 0.204 | 33 | 6 | 0.182 | 0 |
| CHRNA7_ENST00000306901 | CHRNA7 | P36544 | Neuronal acetylcholine receptor subunit alpha-7 | chr15 | GO:1902495 | Not Cancer Driver | No | 71 | 0.141 | 18 | 4 | 0.222 | 0 |
| CHRNA9 | CHRNA9 | Q9UGM1 | Neuronal acetylcholine receptor subunit alpha-9 | chr4 | GO:1902495 | Not Cancer Driver | No | 76 | 0.159 | 23 | 6 | 0.261 | 0 |
| CHRNB1 | CHRNB1 | P11230 | Acetylcholine receptor subunit beta | chr17 | GO:1902495 | Not Cancer Driver | No | 62 | 0.124 | 45 | 9 | 0.2 | 3 |
| CHRNB2 | CHRNB2 | P17787 | Neuronal acetylcholine receptor subunit beta-2 | chr1 | GO:1902495 | Not Cancer Driver | No | 92 | 0.183 | 23 | 2 | 0.087 | 2 |
| CHRNB3 | CHRNB3 | Q05901 | Neuronal acetylcholine receptor subunit beta-3 | chr8 | GO:1902495 | Not Cancer Driver | No | 125 | 0.273 | 4 | 1 | 0.25 | 0 |
| CHRNB4 | CHRNB4 | P30926 | Neuronal acetylcholine receptor subunit beta-4 | chr15 | GO:1902495 | Not Cancer Driver | No | 98 | 0.197 | 30 | 6 | 0.2 | 0 |
| CHRNE | CHRNE | Q04844 | Acetylcholine receptor subunit epsilon | chr17 | GO:1902495 | Not Cancer Driver | No | 52 | 0.105 | 37 | 3 | 0.081 | 13 |
| CLCC1 | CLCC1 | Q96S66 | Chloride channel CLIC-like protein 1 | chr1 | GO:1902495 | Not Cancer Driver | No | 37 | 0.067 | 196 | 19 | 0.097 | 1 |
| CLCN1 | CLCN1 | P35523 | Chloride channel protein 1 | chr7 | GO:1902495 | Not Cancer Driver | No | 224 | 0.227 | 355 | 77 | 0.217 | 54 |
| CLCN2 | CLCN2 | P51788 | Chloride channel protein 2 | chr3 | GO:1902495 | Not Cancer Driver | No | 124 | 0.138 | 224 | 38 | 0.17 | 8 |
| CLCN7 | CLCN7 | P51798 | H(+)/Cl(-) exchange transporter 7 | chr16 | GO:1902495 | Not Cancer Driver | No | 102 | 0.127 | 94 | 7 | 0.074 | 29 |
| CLCNKA | CLCNKA | P51800 | Chloride channel protein ClC-Ka | chr1 | GO:1902495 | Not Cancer Driver | No | 92 | 0.134 | 35 | 3 | 0.086 | 1 |
| CLCNKB | CLCNKB | P51801 | Chloride channel protein ClC-Kb | chr1 | GO:1902495 | Not Cancer Driver | No | 104 | 0.151 | 23 | 9 | 0.391 | 5 |
| CLDN17 | CLDN17 | P56750 | Claudin-17 | chr21 | GO:1902495 | Not Cancer Driver | No | 59 | 0.263 | 6 | 3 | 0.5 | 0 |
| CLDN4 | CLDN4 | O14493 | Claudin-4 | chr7 | GO:1902495 | Not Cancer Driver | No | 40 | 0.191 | 0 | 0 | 0.0 | 0 |
| CLIC1_ENST00000375779 | CLIC1 | O00299 | Chloride intracellular channel protein 1 | chr6 | GO:1902495 | Not Cancer Driver | No | 32 | 0.133 | 27 | 5 | 0.185 | 0 |
| CLIC2 | CLIC2 | O15247 | Chloride intracellular channel protein 2 | chrX | GO:1902495 | Not Cancer Driver | No | 46 | 0.186 | 58 | 6 | 0.103 | 1 |
| CLIC3 | CLIC3 | O95833 | Chloride intracellular channel protein 3 | chr9 | GO:1902495 | Not Cancer Driver | No | 23 | 0.097 | 36 | 3 | 0.083 | 0 |
| CLIC4 | CLIC4 | Q9Y696 | Chloride intracellular channel protein 4 | chr1 | GO:1902495 | Not Cancer Driver | No | 24 | 0.095 | 49 | 4 | 0.082 | 0 |
| CLIC5 | CLIC5 | Q9NZA1 | Chloride intracellular channel protein 5 | chr6 | GO:1902495 | Not Cancer Driver | No | 50 | 0.122 | 205 | 22 | 0.107 | 0 |
| CLIC6 | CLIC6 | Q96NY7 | Chloride intracellular channel protein 6 | chr21 | GO:1902495 | Not Cancer Driver | No | 60 | 0.085 | 500 | 21 | 0.042 | 0 |
| CNGA1_ENST00000420489 | CNGA1 | P29973 | cGMP-gated cation channel alpha-1 | chr4 | GO:1902495 | Not Cancer Driver | No | 136 | 0.198 | 185 | 37 | 0.2 | 1 |
| CNGA2 | CNGA2 | Q16280 | Cyclic nucleotide-gated olfactory channel | chrX | GO:1902495 | Not Cancer Driver | No | 159 | 0.239 | 161 | 33 | 0.205 | 0 |
| CNGA3 | CNGA3 | Q16281 | Cyclic nucleotide-gated cation channel alpha-3 | chr2 | GO:1902495 | Not Cancer Driver | No | 183 | 0.264 | 217 | 67 | 0.309 | 53 |
| CNGA4 | CNGA4 | Q8IV77 | Cyclic nucleotide-gated cation channel alpha-4 | chr11 | GO:1902495 | Not Cancer Driver | No | 132 | 0.23 | 79 | 13 | 0.165 | 0 |
| CNGB1 | CNGB1 | Q14028 | Cyclic nucleotide-gated cation channel beta-1 | chr16 | GO:1902495 | Not Cancer Driver | No | 206 | 0.165 | 789 | 120 | 0.152 | 1 |
| CNGB3 | CNGB3 | Q9NQW8 | Cyclic nucleotide-gated cation channel beta-3 | chr8 | GO:1902495 | Not Cancer Driver | No | 244 | 0.302 | 338 | 123 | 0.364 | 8 |
| CNIH2 | CNIH2 | Q6PI25 | Protein cornichon homolog 2 | chr11 | GO:1902495 | Not Cancer Driver | No | 20 | 0.125 | 0 | 0 | 0.0 | 0 |
| CNIH3 | CNIH3 | Q8TBE1 | Protein cornichon homolog 3 | chr1 | GO:1902495 | Not Cancer Driver | No | 27 | 0.169 | 0 | 0 | 0.0 | 0 |
| CNTNAP2 | CNTNAP2 | Q9UHC6 | Contactin-associated protein-like 2 | chr7 | GO:1902495 | Census | Yes | 570 | 0.428 | 161 | 82 | 0.509 | 0 |
| CPT1C_ENST00000598293 | CPT1C | Q8TCG5 | Carnitine O-palmitoyltransferase 1, brain isoform | chr19 | GO:1902495 | Not Cancer Driver | No | 138 | 0.172 | 93 | 13 | 0.14 | 1 |
| DLG3 | DLG3 | Q92796 | Disks large homolog 3 | chrX | GO:1902495 | Not Cancer Driver | No | 94 | 0.115 | 322 | 30 | 0.093 | 0 |
| DLG4_ENST00000399506 | DLG4 | P78352 | Disks large homolog 4 | chr17 | GO:1902495 | Not Cancer Driver | No | 116 | 0.16 | 232 | 55 | 0.237 | 0 |
| DPP10_ENST00000410059 | DPP10 | Q8N608 | Inactive dipeptidyl peptidase 10 | chr2 | GO:1902495 | Not Cancer Driver | No | 319 | 0.401 | 38 | 17 | 0.447 | 0 |
| DPP6 | DPP6 | P42658 | Dipeptidyl aminopeptidase-like protein 6 | chr7 | GO:1902495 | Not Cancer Driver | No | 244 | 0.282 | 181 | 45 | 0.249 | 1 |
| EPS8_ENST00000645775 | EPS8 | Q12929 | Epidermal growth factor receptor kinase substrate 8 | chr12 | GO:1902495 | Not Cancer Driver | No | 106 | 0.129 | 459 | 54 | 0.118 | 0 |
| FKBP1A | FKBP1A | P62942 | Peptidyl-prolyl cis-trans isomerase FKBP1A | chr20 | GO:1902495 | Not Cancer Driver | No | 15 | 0.139 | 39 | 7 | 0.179 | 0 |
| FXYD1_ENST00000455515 | FXYD1 | O00168 | Phospholemman | chr19 | GO:1902495 | Not Cancer Driver | No | 10 | 0.109 | 22 | 4 | 0.182 | 0 |
| FXYD2 | FXYD2 | P54710 | Sodium/potassium-transporting ATPase subunit gamma | chr11 | GO:1902495 | Not Cancer Driver | No | 2 | 0.03 | 20 | 2 | 0.1 | 1 |
| FXYD4_ENST00000476166 | FXYD4 | P59646 | FXYD domain-containing ion transport regulator 4 | chr10 | GO:1902495 | Not Cancer Driver | No | 9 | 0.101 | 5 | 1 | 0.2 | 0 |
| GABRA1_ENST00000638112 | GABRA1 | P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | chr5 | GO:1902495 | Not Cancer Driver | No | 175 | 0.384 | 58 | 31 | 0.534 | 6 |
| GABRA2_ENST00000356504 | GABRA2 | P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | chr4 | GO:1902495 | Not Cancer Driver | No | 194 | 0.43 | 26 | 13 | 0.5 | 5 |
| GABRA3_ENST00000535043 | GABRA3 | P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | chrX | GO:1902495 | Not Cancer Driver | No | 136 | 0.276 | 47 | 10 | 0.213 | 0 |
| GABRA4 | GABRA4 | P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | chr4 | GO:1902495 | Not Cancer Driver | No | 191 | 0.345 | 179 | 82 | 0.458 | 0 |
| GABRA5_ENST00000355395 | GABRA5 | P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | chr15 | GO:1902495 | Not Cancer Driver | No | 146 | 0.316 | 55 | 14 | 0.255 | 3 |
| GABRA6 | GABRA6 | Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | chr5 | GO:1902495 | Not Cancer Driver | No | 186 | 0.411 | 7 | 2 | 0.286 | 0 |
| GABRB1 | GABRB1 | P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | chr4 | GO:1902495 | Not Cancer Driver | No | 133 | 0.281 | 43 | 14 | 0.326 | 2 |
| GABRB2_ENST00000393959 | GABRB2 | P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | chr5 | GO:1902495 | Not Cancer Driver | No | 165 | 0.322 | 27 | 10 | 0.37 | 1 |
| GABRB3 | GABRB3 | P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | chr15 | GO:1902495 | Not Cancer Driver | No | 178 | 0.376 | 56 | 22 | 0.393 | 9 |
| GABRD | GABRD | O14764 | Gamma-aminobutyric acid receptor subunit delta | chr1 | GO:1902495 | Not Cancer Driver | No | 71 | 0.157 | 19 | 5 | 0.263 | 1 |
| GABRE | GABRE | P78334 | Gamma-aminobutyric acid receptor subunit epsilon | chrX | GO:1902495 | Not Cancer Driver | No | 133 | 0.263 | 73 | 19 | 0.26 | 0 |
| GABRG1 | GABRG1 | Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | chr4 | GO:1902495 | Not Cancer Driver | No | 216 | 0.465 | 7 | 3 | 0.429 | 0 |
| GABRG2_ENST00000639213 | GABRG2 | P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | chr5 | GO:1902495 | Not Cancer Driver | No | 188 | 0.403 | 19 | 13 | 0.684 | 11 |
| GABRG3 | GABRG3 | Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | chr15 | GO:1902495 | Not Cancer Driver | No | 137 | 0.293 | 12 | 5 | 0.417 | 0 |
| GABRP_ENST00000265294 | GABRP | O00591 | Gamma-aminobutyric acid receptor subunit pi | chr5 | GO:1902495 | Not Cancer Driver | No | 81 | 0.184 | 0 | 0 | 0.0 | 0 |
| GABRQ | GABRQ | Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | chrX | GO:1902495 | Not Cancer Driver | No | 158 | 0.25 | 175 | 58 | 0.331 | 0 |
| GABRR1 | GABRR1 | P24046 | Gamma-aminobutyric acid receptor subunit rho-1 | chr6 | GO:1902495 | Not Cancer Driver | No | 93 | 0.194 | 99 | 26 | 0.263 | 0 |
| GABRR2 | GABRR2 | P28476 | Gamma-aminobutyric acid receptor subunit rho-2 | chr6 | GO:1902495 | Not Cancer Driver | No | 64 | 0.138 | 8 | 0 | 0.0 | 0 |
| GABRR3 | GABRR3 | A8MPY1 | Gamma-aminobutyric acid receptor subunit rho-3 | chr3 | GO:1902495 | Not Cancer Driver | No | 76 | 0.163 | 30 | 7 | 0.233 | 0 |
| GLRA1 | GLRA1 | P23415 | Glycine receptor subunit alpha-1 | chr5 | GO:1902495 | Not Cancer Driver | No | 92 | 0.201 | 37 | 2 | 0.054 | 18 |
| GLRA2 | GLRA2 | P23416 | Glycine receptor subunit alpha-2 | chrX | GO:1902495 | Not Cancer Driver | No | 106 | 0.235 | 58 | 14 | 0.241 | 0 |
| GLRA3 | GLRA3 | O75311 | Glycine receptor subunit alpha-3 | chr4 | GO:1902495 | Not Cancer Driver | No | 132 | 0.284 | 32 | 11 | 0.344 | 0 |
| GLRB | GLRB | P48167 | Glycine receptor subunit beta | chr4 | GO:1902495 | Not Cancer Driver | No | 112 | 0.225 | 66 | 12 | 0.182 | 4 |
| GRIA1_ENST00000285900 | GRIA1 | P42261 | Glutamate receptor 1 | chr5 | GO:1902495 | Not Cancer Driver | No | 303 | 0.334 | 104 | 45 | 0.433 | 0 |
| GRIA2_ENST00000264426 | GRIA2 | P42262 | Glutamate receptor 2 | chr4 | GO:1902495 | Not Cancer Driver | No | 290 | 0.328 | 50 | 16 | 0.32 | 14 |
| GRIA3 | GRIA3 | P42263 | Glutamate receptor 3 | chrX | GO:1902495 | Not Cancer Driver | No | 209 | 0.234 | 56 | 15 | 0.268 | 4 |
| GRIA4_ENST00000530497 | GRIA4 | P48058 | Glutamate receptor 4 | chr11 | GO:1902495 | Not Cancer Driver | No | 227 | 0.252 | 63 | 25 | 0.397 | 4 |
| GRIK2 | GRIK2 | Q13002 | Glutamate receptor ionotropic, kainate 2 | chr6 | GO:1902495 | Not Cancer Driver | No | 284 | 0.313 | 57 | 19 | 0.333 | 0 |
| GRIK3 | GRIK3 | Q13003 | Glutamate receptor ionotropic, kainate 3 | chr1 | GO:1902495 | Not Cancer Driver | No | 256 | 0.279 | 38 | 9 | 0.237 | 0 |
| GRIK4_ENST00000438375 | GRIK4 | Q16099 | Glutamate receptor ionotropic, kainate 4 | chr11 | GO:1902495 | Not Cancer Driver | No | 179 | 0.187 | 74 | 8 | 0.108 | 0 |
| GRIK5_ENST00000593562 | GRIK5 | Q16478 | Glutamate receptor ionotropic, kainate 5 | chr19 | GO:1902495 | Not Cancer Driver | No | 176 | 0.18 | 135 | 9 | 0.067 | 0 |
| GRIN1_ENST00000371561 | GRIN1 | Q05586 | Glutamate receptor ionotropic, NMDA 1 | chr9 | GO:1902495 | Not Cancer Driver | No | 88 | 0.094 | 190 | 15 | 0.079 | 13 |
| GRIN2A_ENST00000330684 | GRIN2A | Q12879 | Glutamate receptor ionotropic, NMDA 2A | chr16 | GO:1902495 | Census, Compendium | Yes | 528 | 0.361 | 506 | 207 | 0.409 | 31 |
| GRIN2B | GRIN2B | Q13224 | Glutamate receptor ionotropic, NMDA 2B | chr12 | GO:1902495 | Not Cancer Driver | No | 413 | 0.278 | 426 | 147 | 0.345 | 11 |
| GRIN2C | GRIN2C | Q14957 | Glutamate receptor ionotropic, NMDA 2C | chr17 | GO:1902495 | Not Cancer Driver | No | 111 | 0.09 | 276 | 6 | 0.022 | 0 |
| GRIN2D | GRIN2D | O15399 | Glutamate receptor ionotropic, NMDA 2D | chr19 | GO:1902495 | Not Cancer Driver | No | 125 | 0.094 | 467 | 15 | 0.032 | 1 |
| GRIN3A | GRIN3A | Q8TCU5 | Glutamate receptor ionotropic, NMDA 3A | chr9 | GO:1902495 | Not Cancer Driver | No | 308 | 0.276 | 179 | 22 | 0.123 | 0 |
| GRIN3B | GRIN3B | O60391 | Glutamate receptor ionotropic, NMDA 3B | chr19 | GO:1902495 | Not Cancer Driver | No | 90 | 0.086 | 299 | 23 | 0.077 | 0 |
| HCN1 | HCN1 | O60741 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | chr5 | GO:1902495 | Not Cancer Driver | No | 432 | 0.485 | 365 | 187 | 0.512 | 16 |
| HCN2 | HCN2 | Q9UL51 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | chr19 | GO:1902495 | Not Cancer Driver | No | 75 | 0.084 | 342 | 5 | 0.015 | 0 |
| HCN4 | HCN4 | Q9Y3Q4 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | chr15 | GO:1902495 | Not Cancer Driver | No | 187 | 0.155 | 631 | 58 | 0.092 | 3 |
| HTR3A_ENST00000504030 | HTR3A | P46098 | 5-hydroxytryptamine receptor 3A | chr11 | GO:1902495 | Not Cancer Driver | No | 127 | 0.266 | 45 | 13 | 0.289 | 0 |
| HTR3B | HTR3B | O95264 | 5-hydroxytryptamine receptor 3B | chr11 | GO:1902495 | Not Cancer Driver | No | 91 | 0.206 | 8 | 0 | 0.0 | 0 |
| HTR3C | HTR3C | Q8WXA8 | 5-hydroxytryptamine receptor 3C | chr3 | GO:1902495 | Not Cancer Driver | No | 82 | 0.183 | 35 | 7 | 0.2 | 0 |
| HTR3D | HTR3D | Q70Z44 | 5-hydroxytryptamine receptor 3D | chr3 | GO:1902495 | Not Cancer Driver | No | 61 | 0.134 | 59 | 16 | 0.271 | 0 |
| HTR3E_ENST00000415389 | HTR3E | A5X5Y0 | 5-hydroxytryptamine receptor 3E | chr3 | GO:1902495 | Not Cancer Driver | No | 87 | 0.191 | 56 | 18 | 0.321 | 0 |
| KCNA1 | KCNA1 | Q09470 | Potassium voltage-gated channel subfamily A member 1 | chr12 | GO:1902495 | Not Cancer Driver | No | 176 | 0.356 | 69 | 34 | 0.493 | 17 |
| KCNA10 | KCNA10 | Q16322 | Potassium voltage-gated channel subfamily A member 10 | chr1 | GO:1902495 | Not Cancer Driver | No | 118 | 0.231 | 110 | 30 | 0.273 | 0 |
| KCNA2_ENST00000638616 | KCNA2 | P16389 | Potassium voltage-gated channel subfamily A member 2 | chr1 | GO:1902495 | Not Cancer Driver | No | 96 | 0.192 | 82 | 16 | 0.195 | 5 |
| KCNA3 | KCNA3 | P22001 | Potassium voltage-gated channel subfamily A member 3 | chr1 | GO:1902495 | Not Cancer Driver | No | 120 | 0.209 | 169 | 16 | 0.095 | 0 |
| KCNA4 | KCNA4 | P22459 | Potassium voltage-gated channel subfamily A member 4 | chr11 | GO:1902495 | Not Cancer Driver | No | 213 | 0.326 | 233 | 82 | 0.352 | 0 |
| KCNA5 | KCNA5 | P22460 | Potassium voltage-gated channel subfamily A member 5 | chr12 | GO:1902495 | Not Cancer Driver | No | 213 | 0.347 | 218 | 53 | 0.243 | 0 |
| KCNA6 | KCNA6 | P17658 | Potassium voltage-gated channel subfamily A member 6 | chr12 | GO:1902495 | Not Cancer Driver | No | 178 | 0.336 | 159 | 55 | 0.346 | 0 |
| KCNA7 | KCNA7 | Q96RP8 | Potassium voltage-gated channel subfamily A member 7 | chr19 | GO:1902495 | Not Cancer Driver | No | 62 | 0.136 | 48 | 8 | 0.167 | 0 |
| KCNAB1 | KCNAB1 | Q14722 | Voltage-gated potassium channel subunit beta-1 | chr3 | GO:1902495 | Not Cancer Driver | No | 89 | 0.212 | 83 | 23 | 0.277 | 0 |
| KCNAB2_ENST00000378097 | KCNAB2 | Q13303 | Voltage-gated potassium channel subunit beta-2 | chr1 | GO:1902495 | Not Cancer Driver | No | 41 | 0.112 | 33 | 1 | 0.03 | 0 |
| KCNAB3 | KCNAB3 | O43448 | Voltage-gated potassium channel subunit beta-3 | chr17 | GO:1902495 | Not Cancer Driver | No | 42 | 0.104 | 99 | 4 | 0.04 | 0 |
| KCNB1_ENST00000635465 | KCNB1 | Q14721 | Potassium voltage-gated channel subfamily B member 1 | chr20 | GO:1902495 | Not Cancer Driver | No | 192 | 0.224 | 417 | 100 | 0.24 | 6 |
| KCNB2 | KCNB2 | Q92953 | Potassium voltage-gated channel subfamily B member 2 | chr8 | GO:1902495 | Not Cancer Driver | No | 372 | 0.408 | 502 | 200 | 0.398 | 0 |
| KCNC1_ENST00000379472 | KCNC1 | P48547 | Potassium voltage-gated channel subfamily C member 1 | chr11 | GO:1902495 | Not Cancer Driver | No | 91 | 0.178 | 110 | 18 | 0.164 | 1 |
| KCNC2 | KCNC2 | Q96PR1 | Potassium voltage-gated channel subfamily C member 2 | chr12 | GO:1902495 | Not Cancer Driver | No | 161 | 0.252 | 255 | 63 | 0.247 | 0 |
| KCNC3 | KCNC3 | Q14003 | Potassium voltage-gated channel subfamily C member 3 | chr19 | GO:1902495 | Not Cancer Driver | No | 76 | 0.1 | 405 | 29 | 0.072 | 4 |
| KCNC4 | KCNC4 | Q03721 | Potassium voltage-gated channel subfamily C member 4 | chr1 | GO:1902495 | Not Cancer Driver | No | 105 | 0.165 | 244 | 38 | 0.156 | 0 |
| KCND1 | KCND1 | Q9NSA2 | Potassium voltage-gated channel subfamily D member 1 | chrX | GO:1902495 | Not Cancer Driver | No | 97 | 0.15 | 180 | 30 | 0.167 | 0 |
| KCND2 | KCND2 | Q9NZV8 | Potassium voltage-gated channel subfamily D member 2 | chr7 | GO:1902495 | Not Cancer Driver | No | 220 | 0.349 | 195 | 62 | 0.318 | 0 |
| KCND3 | KCND3 | Q9UK17 | Potassium voltage-gated channel subfamily D member 3 | chr1 | GO:1902495 | Not Cancer Driver | No | 172 | 0.263 | 202 | 44 | 0.218 | 5 |
| KCNE1_ENST00000399284 | KCNE1 | P15382 | Potassium voltage-gated channel subfamily E member 1 | chr21 | GO:1902495 | Not Cancer Driver | No | 35 | 0.271 | 24 | 10 | 0.417 | 9 |
| KCNE2 | KCNE2 | Q9Y6J6 | Potassium voltage-gated channel subfamily E member 2 | chr21 | GO:1902495 | Not Cancer Driver | No | 25 | 0.203 | 2 | 0 | 0.0 | 5 |
| KCNE5 | KCNE5 | Q9UJ90 | Potassium voltage-gated channel subfamily E regulatory beta subunit 5 | chrX | GO:1902495 | Not Cancer Driver | No | 35 | 0.246 | 68 | 26 | 0.382 | 0 |
| KCNF1 | KCNF1 | Q9H3M0 | Potassium voltage-gated channel subfamily F member 1 | chr2 | GO:1902495 | Not Cancer Driver | No | 116 | 0.235 | 73 | 13 | 0.178 | 0 |
| KCNG1 | KCNG1 | Q9UIX4 | Potassium voltage-gated channel subfamily G member 1 | chr20 | GO:1902495 | Not Cancer Driver | No | 123 | 0.24 | 50 | 12 | 0.24 | 0 |
| KCNG2 | KCNG2 | Q9UJ96 | Potassium voltage-gated channel subfamily G member 2 | chr18 | GO:1902495 | Not Cancer Driver | No | 75 | 0.161 | 71 | 4 | 0.056 | 0 |
| KCNG3 | KCNG3 | Q8TAE7 | Potassium voltage-gated channel subfamily G member 3 | chr2 | GO:1902495 | Not Cancer Driver | No | 35 | 0.08 | 22 | 1 | 0.045 | 0 |
| KCNG4 | KCNG4 | Q8TDN1 | Potassium voltage-gated channel subfamily G member 4 | chr16 | GO:1902495 | Not Cancer Driver | No | 117 | 0.225 | 47 | 10 | 0.213 | 0 |
| KCNH1 | KCNH1 | O95259 | Potassium voltage-gated channel subfamily H member 1 | chr1 | GO:1902495 | Not Cancer Driver | No | 247 | 0.25 | 248 | 70 | 0.282 | 10 |
| KCNH2 | KCNH2 | Q12809 | Potassium voltage-gated channel subfamily H member 2 | chr7 | GO:1902495 | Not Cancer Driver | No | 189 | 0.163 | 466 | 50 | 0.107 | 117 |
| KCNH4 | KCNH4 | Q9UQ05 | Potassium voltage-gated channel subfamily H member 4 | chr17 | GO:1902495 | Not Cancer Driver | No | 168 | 0.165 | 402 | 51 | 0.127 | 0 |
| KCNIP1_ENST00000411494 | KCNIP1 | Q9NZI2 | Kv channel-interacting protein 1 | chr5 | GO:1902495 | Not Cancer Driver | No | 58 | 0.256 | 4 | 1 | 0.25 | 0 |
| KCNIP2_ENST00000356640 | KCNIP2 | Q9NS61 | Kv channel-interacting protein 2 | chr10 | GO:1902495 | Not Cancer Driver | No | 34 | 0.126 | 89 | 16 | 0.18 | 0 |
| KCNIP3 | KCNIP3 | Q9Y2W7 | Calsenilin | chr2 | GO:1902495 | Not Cancer Driver | No | 39 | 0.152 | 60 | 13 | 0.217 | 0 |
| KCNIP4 | KCNIP4 | Q6PIL6 | Kv channel-interacting protein 4 | chr4 | GO:1902495 | Not Cancer Driver | No | 59 | 0.236 | 30 | 13 | 0.433 | 0 |
| KCNJ1 | KCNJ1 | P48048 | ATP-sensitive inward rectifier potassium channel 1 | chr11 | GO:1902495 | Not Cancer Driver | No | 83 | 0.212 | 10 | 0 | 0.0 | 13 |
| KCNJ11 | KCNJ11 | Q14654 | ATP-sensitive inward rectifier potassium channel 11 | chr11 | GO:1902495 | Not Cancer Driver | No | 48 | 0.123 | 19 | 3 | 0.158 | 46 |
| KCNJ14_ENST00000342291 | KCNJ14 | Q9UNX9 | ATP-sensitive inward rectifier potassium channel 14 | chr19 | GO:1902495 | Not Cancer Driver | No | 56 | 0.128 | 73 | 10 | 0.137 | 0 |
| KCNJ16_ENST00000283936 | KCNJ16 | Q9NPI9 | Inward rectifier potassium channel 16 | chr17 | GO:1902495 | Not Cancer Driver | No | 88 | 0.211 | 38 | 8 | 0.211 | 5 |
| KCNJ2_ENST00000535240 | KCNJ2 | P63252 | Inward rectifier potassium channel 2 | chr17 | GO:1902495 | Not Cancer Driver | No | 103 | 0.241 | 49 | 11 | 0.224 | 12 |
| KCNJ3 | KCNJ3 | P48549 | G protein-activated inward rectifier potassium channel 1 | chr2 | GO:1902495 | Not Cancer Driver | No | 189 | 0.377 | 162 | 64 | 0.395 | 0 |
| KCNJ4 | KCNJ4 | P48050 | Inward rectifier potassium channel 4 | chr22 | GO:1902495 | Not Cancer Driver | No | 103 | 0.231 | 62 | 16 | 0.258 | 0 |
| KCNJ5_ENST00000533599 | KCNJ5 | P48544 | G protein-activated inward rectifier potassium channel 4 | chr11 | GO:1902495 | Census | Yes | 87 | 0.208 | 51 | 6 | 0.118 | 6 |
| KCNJ6_ENST00000645093 | KCNJ6 | P48051 | G protein-activated inward rectifier potassium channel 2 | chr21 | GO:1902495 | Not Cancer Driver | No | 106 | 0.251 | 75 | 13 | 0.173 | 1 |
| KCNJ8 | KCNJ8 | Q15842 | ATP-sensitive inward rectifier potassium channel 8 | chr12 | GO:1902495 | Not Cancer Driver | No | 99 | 0.233 | 68 | 22 | 0.324 | 1 |
| KCNK1 | KCNK1 | O00180 | Potassium channel subfamily K member 1 | chr1 | GO:1902495 | Not Cancer Driver | No | 65 | 0.193 | 21 | 4 | 0.19 | 0 |
| KCNK2 | KCNK2 | O95069 | Potassium channel subfamily K member 2 | chr1 | GO:1902495 | Not Cancer Driver | No | 109 | 0.256 | 40 | 10 | 0.25 | 0 |
| KCNK4 | KCNK4 | Q9NYG8 | Potassium channel subfamily K member 4 | chr11 | GO:1902495 | Not Cancer Driver | No | 34 | 0.087 | 142 | 7 | 0.049 | 2 |
| KCNK6 | KCNK6 | Q9Y257 | Potassium channel subfamily K member 6 | chr19 | GO:1902495 | Not Cancer Driver | No | 39 | 0.125 | 22 | 4 | 0.182 | 0 |
| KCNMA1 | KCNMA1 | Q12791 | Calcium-activated potassium channel subunit alpha-1 | chr10 | GO:1902495 | Not Cancer Driver | No | 222 | 0.18 | 225 | 39 | 0.173 | 5 |
| KCNMB1 | KCNMB1 | Q16558 | Calcium-activated potassium channel subunit beta-1 | chr5 | GO:1902495 | Not Cancer Driver | No | 49 | 0.257 | 0 | 0 | 0.0 | 0 |
| KCNMB2_ENST00000452583 | KCNMB2 | Q9Y691 | Calcium-activated potassium channel subunit beta-2 | chr3 | GO:1902495 | Not Cancer Driver | No | 61 | 0.26 | 0 | 0 | 0.0 | 0 |
| KCNMB3 | KCNMB3 | Q9NPA1 | Calcium-activated potassium channel subunit beta-3 | chr3 | GO:1902495 | Not Cancer Driver | No | 27 | 0.097 | 22 | 2 | 0.091 | 0 |
| KCNMB4 | KCNMB4 | Q86W47 | Calcium-activated potassium channel subunit beta-4 | chr12 | GO:1902495 | Not Cancer Driver | No | 41 | 0.195 | 0 | 0 | 0.0 | 0 |
| KCNN1 | KCNN1 | Q92952 | Small conductance calcium-activated potassium channel protein 1 | chr19 | GO:1902495 | Not Cancer Driver | No | 83 | 0.153 | 192 | 19 | 0.099 | 0 |
| KCNN4 | KCNN4 | O15554 | Intermediate conductance calcium-activated potassium channel protein 4 | chr19 | GO:1902495 | Not Cancer Driver | No | 60 | 0.141 | 31 | 6 | 0.194 | 3 |
| KCNQ1 | KCNQ1 | P51787 | Potassium voltage-gated channel subfamily KQT member 1 | chr11 | GO:1902495 | Not Cancer Driver | No | 78 | 0.115 | 219 | 20 | 0.091 | 132 |
| KCNQ2 | KCNQ2 | O43526 | Potassium voltage-gated channel subfamily KQT member 2 | chr20 | GO:1902495 | Not Cancer Driver | No | 171 | 0.196 | 393 | 81 | 0.206 | 37 |
| KCNQ3 | KCNQ3 | O43525 | Potassium voltage-gated channel subfamily KQT member 3 | chr8 | GO:1902495 | Not Cancer Driver | No | 249 | 0.286 | 411 | 109 | 0.265 | 3 |
| KCNQ4_ENST00000347132 | KCNQ4 | P56696 | Potassium voltage-gated channel subfamily KQT member 4 | chr1 | GO:1902495 | Not Cancer Driver | No | 83 | 0.119 | 267 | 31 | 0.116 | 7 |
| KCNQ5_ENST00000370398 | KCNQ5 | Q9NR82 | Potassium voltage-gated channel subfamily KQT member 5 | chr6 | GO:1902495 | Not Cancer Driver | No | 241 | 0.259 | 408 | 96 | 0.235 | 4 |
| KCNS1 | KCNS1 | Q96KK3 | Potassium voltage-gated channel subfamily S member 1 | chr20 | GO:1902495 | Not Cancer Driver | No | 52 | 0.099 | 64 | 3 | 0.047 | 0 |
| KCNS2_ENST00000521839 | KCNS2 | Q9ULS6 | Potassium voltage-gated channel subfamily S member 2 | chr8 | GO:1902495 | Not Cancer Driver | No | 124 | 0.26 | 29 | 7 | 0.241 | 0 |
| KCNS3_ENST00000304101 | KCNS3 | Q9BQ31 | Potassium voltage-gated channel subfamily S member 3 | chr2 | GO:1902495 | Not Cancer Driver | No | 103 | 0.21 | 23 | 2 | 0.087 | 0 |
| KCNV1 | KCNV1 | Q6PIU1 | Potassium voltage-gated channel subfamily V member 1 | chr8 | GO:1902495 | Not Cancer Driver | No | 147 | 0.294 | 30 | 4 | 0.133 | 0 |
| KCNV2 | KCNV2 | Q8TDN2 | Potassium voltage-gated channel subfamily V member 2 | chr9 | GO:1902495 | Not Cancer Driver | No | 104 | 0.191 | 120 | 22 | 0.183 | 5 |
| LRRC26 | LRRC26 | Q2I0M4 | Leucine-rich repeat-containing protein 26 | chr9 | GO:1902495 | Not Cancer Driver | No | 3 | 0.009 | 41 | 2 | 0.049 | 0 |
| LRRC38 | LRRC38 | Q5VT99 | Leucine-rich repeat-containing protein 38 | chr1 | GO:1902495 | Not Cancer Driver | No | 24 | 0.082 | 12 | 2 | 0.167 | 0 |
| LRRC52 | LRRC52 | Q8N7C0 | Leucine-rich repeat-containing protein 52 | chr1 | GO:1902495 | Not Cancer Driver | No | 61 | 0.195 | 15 | 4 | 0.267 | 0 |
| MCU | MCU | Q8NE86 | Calcium uniporter protein, mitochondrial | chr10 | GO:1902495 | Not Cancer Driver | No | 41 | 0.117 | 13 | 0 | 0.0 | 0 |
| MCUB | MCUB | Q9NWR8 | Calcium uniporter regulatory subunit MCUb, mitochondrial | chr4 | GO:1902495 | Not Cancer Driver | No | 33 | 0.098 | 24 | 1 | 0.042 | 0 |
| MICU1 | MICU1 | Q9BPX6 | Calcium uptake protein 1, mitochondrial | chr10 | GO:1902495 | Not Cancer Driver | No | 50 | 0.105 | 97 | 18 | 0.186 | 0 |
| MICU2 | MICU2 | Q8IYU8 | Calcium uptake protein 2, mitochondrial | chr13 | GO:1902495 | Not Cancer Driver | No | 45 | 0.104 | 10 | 1 | 0.1 | 0 |
| MICU3 | MICU3 | Q86XE3 | Calcium uptake protein 3, mitochondrial | chr8 | GO:1902495 | Not Cancer Driver | No | 72 | 0.136 | 89 | 8 | 0.09 | 0 |
| OLFM2 | OLFM2 | O95897 | Noelin-2 | chr19 | GO:1902495 | Not Cancer Driver | No | 74 | 0.163 | 16 | 2 | 0.125 | 0 |
| OLFM3 | OLFM3 | Q96PB7 | Noelin-3 | chr1 | GO:1902495 | Not Cancer Driver | No | 148 | 0.31 | 44 | 17 | 0.386 | 0 |
| OSTM1 | OSTM1 | Q86WC4 | Osteopetrosis-associated transmembrane protein 1 | chr6 | GO:1902495 | Not Cancer Driver | No | 31 | 0.093 | 24 | 4 | 0.167 | 0 |
| PLN | PLN | P26678 | Cardiac phospholamban | chr6 | GO:1902495 | Not Cancer Driver | No | 10 | 0.192 | 0 | 0 | 0.0 | 3 |
| PORCN | PORCN | Q9H237 | Protein-serine O-palmitoleoyltransferase porcupine | chrX | GO:1902495 | Not Cancer Driver | No | 77 | 0.167 | 0 | 0 | 0.0 | 15 |
| PTK2B_ENST00000346049 | PTK2B | Q14289 | Protein-tyrosine kinase 2-beta | chr8 | GO:1902495 | Not Cancer Driver | No | 161 | 0.16 | 261 | 37 | 0.142 | 0 |
| RYR1 | RYR1 | P21817 | Ryanodine receptor 1 | chr19 | GO:1902495 | Not Cancer Driver | No | 1003 | 0.199 | 1186 | 233 | 0.196 | 154 |
| SCN10A | SCN10A | Q9Y5Y9 | Sodium channel protein type 10 subunit alpha | chr3 | GO:1902495 | Not Cancer Driver | No | 513 | 0.262 | 435 | 131 | 0.301 | 2 |
| SCN11A | SCN11A | Q9UI33 | Sodium channel protein type 11 subunit alpha | chr3 | GO:1902495 | Not Cancer Driver | No | 475 | 0.265 | 198 | 61 | 0.308 | 9 |
| SCN1A_ENST00000423058 | SCN1A | P35498 | Sodium channel protein type 1 subunit alpha | chr2 | GO:1902495 | Not Cancer Driver | No | 497 | 0.247 | 455 | 121 | 0.266 | 396 |
| SCN1B_ENST00000262631 | SCN1B | Q07699 | Sodium channel subunit beta-1 | chr19 | GO:1902495 | Not Cancer Driver | No | 35 | 0.161 | 4 | 1 | 0.25 | 5 |
| SCN2A_ENST00000637266 | SCN2A | Q99250 | Sodium channel protein type 2 subunit alpha | chr2 | GO:1902495 | Not Cancer Driver | No | 502 | 0.25 | 435 | 133 | 0.306 | 65 |
| SCN2B | SCN2B | O60939 | Sodium channel subunit beta-2 | chr11 | GO:1902495 | Not Cancer Driver | No | 46 | 0.214 | 52 | 7 | 0.135 | 2 |
| SCN3A_ENST00000360093 | SCN3A | Q9NY46 | Sodium channel protein type 3 subunit alpha | chr2 | GO:1902495 | Not Cancer Driver | No | 415 | 0.207 | 432 | 83 | 0.192 | 6 |
| SCN3B_ENST00000299333 | SCN3B | Q9NY72 | Sodium channel subunit beta-3 | chr11 | GO:1902495 | Not Cancer Driver | No | 63 | 0.293 | 16 | 5 | 0.312 | 3 |
| SCN4A | SCN4A | P35499 | Sodium channel protein type 4 subunit alpha | chr17 | GO:1902495 | Not Cancer Driver | No | 324 | 0.176 | 372 | 80 | 0.215 | 60 |
| SCN4B | SCN4B | Q8IWT1 | Sodium channel subunit beta-4 | chr11 | GO:1902495 | Not Cancer Driver | No | 23 | 0.101 | 46 | 4 | 0.087 | 3 |
| SCN5A_ENST00000333535 | SCN5A | Q14524 | Sodium channel protein type 5 subunit alpha | chr3 | GO:1902495 | Not Cancer Driver | No | 491 | 0.244 | 550 | 144 | 0.262 | 190 |
| SCN7A_ENST00000409855 | SCN7A | Q01118 | Sodium channel protein type 7 subunit alpha | chr2 | GO:1902495 | Not Cancer Driver | No | 395 | 0.235 | 171 | 43 | 0.251 | 0 |
| SCN8A | SCN8A | Q9UQD0 | Sodium channel protein type 8 subunit alpha | chr12 | GO:1902495 | Not Cancer Driver | No | 290 | 0.146 | 460 | 75 | 0.163 | 28 |
| SCN9A_ENST00000642356 | SCN9A | Q15858 | Sodium channel protein type 9 subunit alpha | chr2 | GO:1902495 | Not Cancer Driver | No | 461 | 0.232 | 490 | 126 | 0.257 | 21 |
| SCNN1A_ENST00000228916 | SCNN1A | P37088 | Amiloride-sensitive sodium channel subunit alpha | chr12 | GO:1902495 | Not Cancer Driver | No | 73 | 0.109 | 146 | 21 | 0.144 | 5 |
| SCNN1B | SCNN1B | P51168 | Amiloride-sensitive sodium channel subunit beta | chr16 | GO:1902495 | Not Cancer Driver | No | 90 | 0.141 | 62 | 4 | 0.065 | 13 |
| SCNN1D | SCNN1D | P51172 | Amiloride-sensitive sodium channel subunit delta | chr1 | GO:1902495 | Not Cancer Driver | No | 56 | 0.07 | 210 | 9 | 0.043 | 0 |
| SCNN1G | SCNN1G | P51170 | Amiloride-sensitive sodium channel subunit gamma | chr16 | GO:1902495 | Not Cancer Driver | No | 129 | 0.199 | 57 | 11 | 0.193 | 0 |
| SHISA6_ENST00000409168 | SHISA6 | Q6ZSJ9 | Protein shisa-6 | chr17 | GO:1902495 | Not Cancer Driver | No | 29 | 0.058 | 330 | 22 | 0.067 | 0 |
| SHISA7 | SHISA7 | A6NL88 | Protein shisa-7 | chr19 | GO:1902495 | Not Cancer Driver | No | 13 | 0.024 | 429 | 12 | 0.028 | 0 |
| SHISA9 | SHISA9 | B4DS77 | Protein shisa-9 | chr16 | GO:1902495 | Not Cancer Driver | No | 28 | 0.066 | 285 | 23 | 0.081 | 0 |
| SLC26A6 | SLC26A6 | Q9BXS9 | Solute carrier family 26 member 6 | chr3 | GO:1902495 | Not Cancer Driver | No | 68 | 0.09 | 87 | 13 | 0.149 | 0 |
| SLC5A3 | SLC5A3 | P53794 | Sodium/myo-inositol cotransporter | chr21 | GO:1902495 | Not Cancer Driver | No | 81 | 0.113 | 73 | 6 | 0.082 | 0 |
| SLC9A1 | SLC9A1 | P19634 | Sodium/hydrogen exchanger 1 | chr1 | GO:1902495 | Not Cancer Driver | No | 89 | 0.109 | 251 | 29 | 0.116 | 1 |
| SMDT1 | SMDT1 | Q9H4I9 | Essential MCU regulator, mitochondrial | chr22 | GO:1902495 | Not Cancer Driver | No | 6 | 0.056 | 6 | 0 | 0.0 | 0 |
| STXBP5 | STXBP5 | Q5T5C0 | Syntaxin-binding protein 5 | chr6 | GO:1902495 | Not Cancer Driver | No | 128 | 0.111 | 344 | 46 | 0.134 | 0 |
| TMEM206_ENST00000261455 | PACC1 | Q9H813 | Proton-activated chloride channel | chr1 | GO:1902495 | Not Cancer Driver | No | 51 | 0.146 | 32 | 5 | 0.156 | 0 |
| TRPM4 | TRPM4 | Q8TD43 | Transient receptor potential cation channel subfamily M member 4 | chr19 | GO:1902495 | Not Cancer Driver | No | 152 | 0.125 | 149 | 18 | 0.121 | 12 |
| TTYH1_ENST00000376530 | TTYH1 | Q9H313 | Protein tweety homolog 1 | chr19 | GO:1902495 | Not Cancer Driver | No | 56 | 0.124 | 21 | 3 | 0.143 | 0 |
| TTYH2 | TTYH2 | Q9BSA4 | Protein tweety homolog 2 | chr17 | GO:1902495 | Not Cancer Driver | No | 63 | 0.118 | 68 | 19 | 0.279 | 0 |
| TTYH3 | TTYH3 | Q9C0H2 | Protein tweety homolog 3 | chr7 | GO:1902495 | Not Cancer Driver | No | 48 | 0.092 | 91 | 14 | 0.154 | 0 |
| VWC2 | VWC2 | Q2TAL6 | Brorin | chr7 | GO:1902495 | Not Cancer Driver | No | 51 | 0.157 | 127 | 7 | 0.055 | 0 |
| VWC2L | VWC2L | B2RUY7 | von Willebrand factor C domain-containing protein 2-like | chr2 | GO:1902495 | Not Cancer Driver | No | 75 | 0.338 | 10 | 4 | 0.4 | 0 |